DK1112747T3 - Salmonellavaccine, som ikke inducerer antistoffer mod flagellin eller flageller - Google Patents

Salmonellavaccine, som ikke inducerer antistoffer mod flagellin eller flageller

Info

Publication number
DK1112747T3
DK1112747T3 DK00204630T DK00204630T DK1112747T3 DK 1112747 T3 DK1112747 T3 DK 1112747T3 DK 00204630 T DK00204630 T DK 00204630T DK 00204630 T DK00204630 T DK 00204630T DK 1112747 T3 DK1112747 T3 DK 1112747T3
Authority
DK
Denmark
Prior art keywords
flagella
flagellin
induce antibodies
salmonella vaccine
relates
Prior art date
Application number
DK00204630T
Other languages
Danish (da)
English (en)
Inventor
Petrus Johannes Maria Nuijten
Maarten Hendrik Witvliet
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK1112747T3 publication Critical patent/DK1112747T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00204630T 1999-12-28 2000-12-19 Salmonellavaccine, som ikke inducerer antistoffer mod flagellin eller flageller DK1112747T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99204564 1999-12-28
EP00204630A EP1112747B1 (en) 1999-12-28 2000-12-19 Salmonella vaccine not inducing antibodies against flagellin or flagella

Publications (1)

Publication Number Publication Date
DK1112747T3 true DK1112747T3 (da) 2004-10-25

Family

ID=8241112

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00204630T DK1112747T3 (da) 1999-12-28 2000-12-19 Salmonellavaccine, som ikke inducerer antistoffer mod flagellin eller flageller

Country Status (15)

Country Link
US (2) US20010021386A1 (enExample)
EP (1) EP1112747B1 (enExample)
JP (1) JP5745731B2 (enExample)
AT (1) ATE269104T1 (enExample)
AU (1) AU783508B2 (enExample)
BR (1) BR0006291B1 (enExample)
CA (1) CA2329676A1 (enExample)
DE (1) DE60011560T2 (enExample)
DK (1) DK1112747T3 (enExample)
ES (1) ES2222152T3 (enExample)
HU (1) HU226192B1 (enExample)
MX (1) MXPA00012796A (enExample)
PL (1) PL206377B1 (enExample)
PT (1) PT1112747E (enExample)
TR (1) TR200401569T4 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4751570B2 (ja) * 2002-09-11 2011-08-17 東レ・ダウコーニング株式会社 オルガノポリシロキサン変性多糖類およびその製造方法
EP2517723B1 (en) 2006-09-18 2019-11-06 The Board of Trustees of The University of Arkansas Compositions and methods of enhancing immune responses
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
BRPI0818736A2 (pt) * 2007-10-30 2017-06-13 Univ Arkansas composições e métodos para intensificar imunorrepostas à bactéria flagelada
WO2009059298A2 (en) 2007-11-01 2009-05-07 Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancinc immune responses to eimeria
CA2703519C (en) 2007-11-09 2017-04-18 The Salk Institute For Biological Studies Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors
CN102811734B (zh) 2010-01-21 2016-02-10 阿肯色大学评议会 增强免疫应答的疫苗载体和方法
CA2800830C (en) 2010-06-09 2020-09-08 The Board Of Trustees Of The University Of Arkansas Vaccine and methods to reduce campylobacter infection
KR101449417B1 (ko) 2012-06-20 2014-10-27 한국외국어대학교 연구산학협력단 살모넬라 엔테리카의 박테리오파아지 및 그 용도
WO2014097154A1 (en) 2012-12-20 2014-06-26 Zakład Badawczo-Wdrożeniowy Ośrodka Salmonella "Immunolab" Sp. Z O.O. A polyvalent combined immunising and/or therapeutic preparation for use in bacterial infections or food poisoning, particularly salmonellosis, a method for production of this preparation, its use and a vaccine comprising this preparation
HUE047484T2 (hu) 2013-02-14 2020-04-28 Univ Arkansas Készítmények és eljárások eimeria elleni immunválasz fokozására vagy eimeria-fertõzés korlátozására
US9845341B2 (en) 2013-03-11 2017-12-19 The Brigham And Women's Hospital, Inc. Vibro-based delivery system and immune suppression
US10376571B2 (en) 2013-03-15 2019-08-13 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to enteric pathogens
KR20190015712A (ko) 2016-05-03 2019-02-14 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 면역자극 및 항원 폴리펩티드를 포함하는 효모 백신 벡터, 및 그를 이용하는 방법
CN111374094B (zh) * 2020-03-02 2022-04-19 扬州大学 驴源马流产沙门氏菌经皮下致非妊娠期小鼠子宫感染模型的建立方法
CN118773056B (zh) * 2024-07-10 2025-07-08 山东省滨州畜牧兽医研究院 一种马流产沙门氏菌灭活疫苗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1109179A (en) * 1964-09-30 1968-04-10 Nat Res Dev Improvements relating to typhoid and paratyphoid vaccines
ES2060580T3 (es) * 1986-03-11 1994-12-01 Shionogi & Co Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.
US6130082A (en) * 1988-05-05 2000-10-10 American Cyanamid Company Recombinant flagellin vaccines
DE68922394T2 (de) * 1988-05-05 1995-10-05 Praxis Biolog Inc Rekombinante vakzine von flagellin.
AU640118B2 (en) * 1988-12-19 1993-08-19 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur Meningococcal class 1 outer-membrane protein vaccine
DK0744937T3 (da) * 1994-02-18 2002-10-28 Solidose L L C Vaccination af dyr med tørrede, pelleterede biologiske materialer
GB9621091D0 (en) * 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
US6190669B1 (en) * 1998-05-13 2001-02-20 University Of Maryland, Baltimore Attenuated mutants of salmonella which constitutively express the Vi antigen

Also Published As

Publication number Publication date
EP1112747A1 (en) 2001-07-04
BR0006291A (pt) 2001-11-27
PL206377B1 (pl) 2010-08-31
JP5745731B2 (ja) 2015-07-08
ATE269104T1 (de) 2004-07-15
HUP0005010A2 (en) 2002-06-29
HU0005010D0 (enExample) 2001-02-28
PT1112747E (pt) 2004-10-29
ES2222152T3 (es) 2005-02-01
MXPA00012796A (es) 2002-05-23
US20080069843A1 (en) 2008-03-20
JP2001186874A (ja) 2001-07-10
HU226192B1 (en) 2008-06-30
DE60011560D1 (de) 2004-07-22
EP1112747B1 (en) 2004-06-16
CA2329676A1 (en) 2001-06-28
AU783508B2 (en) 2005-11-03
BR0006291B1 (pt) 2014-02-18
PL344851A1 (en) 2001-07-02
US20010021386A1 (en) 2001-09-13
AU7245300A (en) 2001-07-05
DE60011560T2 (de) 2005-08-18
TR200401569T4 (tr) 2004-07-21
HUP0005010A3 (en) 2004-07-28

Similar Documents

Publication Publication Date Title
ATE269104T1 (de) Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert
EP1499191A4 (en) REGULATED ATTENUATION OF LIVE VACCINATES TO IMPROVE THE CROSS IMMUNE PROTECTION FUNCTION
BRPI0509606A (pt) emulsões de óleo-em-água microfluidizadas e composições para vacinas
WO2004060308A3 (en) Thiosemicarbazones as anti-virals and immunopotentiators
ATE556718T1 (de) Neisseria meningitidis kombinationimpfstoffe
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
ATE426412T1 (de) Adjuvante influenza-vakzine
WO2004062597A3 (en) Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
ATE446368T1 (de) Antigene aus neisseria meningitidis
BR9813930A (pt) antìgeno neisserial
WO2004030608A3 (en) Nanoemulsion vaccines
ATE269341T1 (de) Verbindungen mit immunologischem adjuvanseffekt
DE69934225D1 (de) Kombinierte meningitis b/c impfstoffe
TW200633719A (en) Glycoconjugate vaccines containing peptidoglycan
NO20023935L (no) Ny, ikke-antigen, mukosal adjuvansformulering som modulerer effektene av substanser inkludert vaksineantigener, i kontakt medmukosale kroppsoverflater
ATE461710T1 (de) Nipah-virus-impfstoffe
ZA200000370B (en) Novel antigenic class of avian reoviruses.
ITMO20040351A1 (it) ''confezione per prodotti framaceutici,medicinali o simili,particolarmente fitofarmaci o fitosanitari''.
SG147465A1 (en) Vaccine
FI971402A0 (fi) Menetelmä voimistettujen antigeenisten Helico-bacter-lajien ja niitä sisältävien rokotteiden valmistamiseksi
DK1074266T3 (da) Levende svækkede bakterier til anvendelse i vaccine
WO2005021031A3 (en) Live attenuated bacterial vaccine
CY1114309T1 (el) Εμβολιο ροταϊου
DK1204420T3 (da) Trehaloseproducerende prokaryotiske celler som vacciner
TH87147B (th) วัคซีนสำหรับการทำให้เกิดภูมิคุ้มกันที่ต้านเชื้อเฮลิโคแมคเตอร์